People living with HIV who contract mpox should start antiretroviral therapy (ART) as soon as possible, according to updated ...

The European Medicines Agency has recommended authorizing a twice-yearly injectable drug to prevent HIV. Scientists say this ...

In 2024, studies suggested that lenacapavir, already used to treat people with HIV, was nearly 100% effective in stopping ...

The drug is administered subcutaneously twice a year, making it easier for high-risk patients to comply with prophylaxis.

The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

To find out what may be behind these numbers, Dr. Ann Khalsa, a clinician at the Valleywise Health McDowell Clinic spoke with ...

The task force determines which preventive services insurers must cover at no cost to patients.

Healio received an APEX award for a 2024 report on the cloudy future of HIV vaccine research in the age of long-acting ...

Quality of life in people living with HIV was lower in those who had weight gain from adherence to antiretroviral therapy.

Just diagnosed with HIV? We have answers to your most commonly-asked questions, including what it means to be "undetectable." ...

An epidemic that's been sustained for 44 years might finally be quelled, with the milestone approval of the first HIV drug ...

The department lost $1.3 million in crucial funding as the Trump administration cuts government money for HIV research, ...